Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift
about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOncogenes strike a balance between cellular growth and homeostasisMourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complexSanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current UsesWill targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies?Glutaminolysis and autophagy in cancerIdentification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi.Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from Type 2 diabeticsmTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitationOutlook on PI3K/AKT/mTOR inhibition in acute leukemia.Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.Using genetic buffering relationships identified in fission yeast to reveal susceptibilities in cells lacking hamartin or tuberin function.Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma.
P2860
Q26766128-F1FAA33A-01D8-4D90-8D57-A3EBF6D47B23Q26798085-57CF1B38-1923-4F5E-B6B1-2CD4A4780DDFQ28070171-213085AF-44C5-4FD4-8362-CC8970AA1268Q28077612-62E381E6-00AE-43E4-A31B-EA32C1ADF758Q28078957-78F6137A-DAE5-4C27-AB7E-5FE2458BE4D6Q36111779-97E02819-4931-45E3-AF83-51BB4E38EA38Q36274085-F991E86D-B2D8-4F13-8B27-9DDC759CC74DQ36339315-8914579C-51AE-4B9F-B71A-EBFE35521270Q37604295-73FC4987-D2A1-4E77-B691-A9E89AAA17A6Q38521775-A1FBC4DC-4A8A-4A72-86BA-9AB9DEEA1D5AQ38793867-1919A03D-9A5F-49DE-9A23-635674CC6B93Q48042369-2CE6244D-FD98-4686-BC55-1FB6F893F159Q50661808-3425E108-1E88-4CCC-B1FB-E954756A21BF
P2860
Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@ast
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@en
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@nl
type
label
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@ast
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@en
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@nl
prefLabel
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@ast
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@en
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@nl
P2093
P2860
P3181
P1476
Therapeutic targeting of cellu ...... ctive mTORC1: a paradigm shift
@en
P2093
D. Medvetz
E. P. Henske
P2860
P3181
P356
10.1158/1541-7786.MCR-14-0343
P407
P577
2015-01-01T00:00:00Z